Intensity Therapeutics, Inc. (INTS) Reports In-Line Q3 EPS

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• S&P announces major changes in S&P 100, S&P 500, S&P 400
• Epic Gold plans $3.15M non-brokered private placement